Within the medical device industry, 8G-26G bone marrow biopsy needles are categorized into two main variants: sterile disposable models and reusable models. Both types are standardized by qualified manufacturers yet differ noticeably in material technology, sterilization protocols, applicable scenarios and compliance benchmarks. Medical institutions must select appropriate products based on clinical demands and hospital infection control specifications, representing essential industrial knowledge for procurement and clinical practice. Both variants cover all gauges ranging from 8G to 26G and feature standard configurations including ergonomic handles, depth markers and tapered tips, sharing identical core functionality while differing primarily in reusability and safety criteria.

Sterile disposable bone marrow biopsy needles dominate current clinical practice and represent the core product promoted by the industry. Manufactured from medical-grade stainless steel, they undergo full ethylene oxide sterilization before delivery, packed in individual sterile pouches ready for single-patient use and subsequent disposal. From a compliance perspective, manufacturers follow strict production protocols for Class III sterile medical devices with operations carried out in dust-free sterile workshops. Products are pyrogen-free, bacteria-free and non-sensitizing, fundamentally eliminating cross-infection risks. Hematology patients commonly suffer from compromised immunity and chemotherapy-induced myelosuppression with strict infection prevention demands. Disposable instruments remove hazards from incomplete disinfection and cross-contamination, suitable for tertiary hospitals, specialized hematology hospitals and routine outpatient biopsy surgeries.

Reusable bone marrow biopsy needles constitute a classic industrial product category, constructed with thickened premium medical stainless steel for enhanced structural strength. The material withstands repeated high-pressure steam sterilization and immersion disinfection without degradation. Manufacturers strengthen material ductility and corrosion resistance during production for reusable variants, alongside tight control over surface finish to avoid rusting, burr formation and faded markers after repeated disinfection. Their primary advantage lies in cost efficiency with lower consumable expenses, making them suitable for primary medical institutions, physical examination centers, scientific research and teaching demonstrations with low infection risks.

Clear usage boundaries exist for both categories in clinical practice. Disposable biopsy needles are strictly prohibited from repeated use. Reapplication leads to blunted tips, residual tissue and bacterial contamination, triggering patient infection, aggravated puncture trauma and violations of hospital infection management standards. Reusable biopsy needles must follow standardized disinfection workflows: thorough cleaning, sterilization and quality inspection after each use. Instruments showing deformed tips, rust or worn scales require immediate retirement.

Both versions are equipped with standard Ruhr II fittings, beveled stylets, tapered distal tips, centimeter graduation markings and ergonomic handles to guarantee consistent operation feel and puncture precision. Manufacturers can adjust product attributes flexibly according to client demands and provide customized disposable or reusable specifications. As global hospital infection standards continuously tighten, sterile disposable bone marrow biopsy needles capture growing market share as the mainstream industrial trend. Meanwhile, reusable products maintain stable demand in primary healthcare and research fields relying on cost advantages. The two product types complement each other to satisfy diversified market demands across the industry.